1. Richelsen B. Action of growth hormone in adipose tissue. Horm. Res. 1997, 48 (Suppl. 5): 105–110.
2. Rosen T., Bengtsson B.A. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 1990, 336: 285–288.
3. Boot A.M., Engels M.A.M.J., Boerma G.J.M., Krenning E.P., de Muinck Keizer-Schrama S.M.P.F. Changes in bone mineral density, body composition, and lipid metabolism during growth hormone (GH) treatment in children with GH deficiency. J. Clin. Endocrinol. Metab. 1997, 82: 2423–2428.
4. Degerblad M., Elgingy N., Hall K., Sjöberg H.E., Thoren M. Potent effect of recombinant human growth hormone on bone mineral density and body composition in adults with panhypopituitarism. Acta Endocr. (Copenh) 1992, 126: 387–393.
5. Laron Z., Klinger B. Body fat in Laron syndrome patients: effect of insulinlike growth factor I treatment. Horm. Res. 1993, 40: 16–22.